<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26635636</article-id>
<article-id pub-id-type="pmc">4648068</article-id>
<article-id pub-id-type="doi">10.3389/fpsyt.2015.00159</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Seong-Wook</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>†</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/211231" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Taesup</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>†</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/266805" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sukchan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/268117" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Center for Cognition and Sociality, Institute for Basic Science</institution>, <addr-line>Daejeon</addr-line>, <country>South Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Physiology, Seoul National University College of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Blazej Misiak, Wroclaw Medical University, Poland</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Madhara Udawela, The Florey Institute of Neuroscience and Mental Health, Australia; Sergej Nadalin, University of Rijeka, Croatia</p>
</fn>
<corresp content-type="corresp" id="cor1">*Correspondence: Seong-Wook Kim, <email>seongwook0205@gmail.com</email></corresp>
<fn fn-type="other" id="fn001">
<p><sup>†</sup>Seong-Wook Kim and Taesup Cho have contributed equally to this work.</p>
</fn>
<fn fn-type="other" id="fn002">
<p>Specialty section: This article was submitted to Affective Disorders and Psychosomatic Research, a section of the journal Frontiers in Psychiatry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>6</volume>
<elocation-id>159</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 Kim, Cho and Lee.</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Kim, Cho and Lee</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Schizophrenia is a mental disorder that is characterized by various abnormal symptoms. Previous studies indicate decreased expression of phospholipase C-β1 (PLC-β1) in the brains of patients with schizophrenia. PLC-β1-null (PLC-β1<sup>−/−</sup>) mice exhibit multiple endophenotypes of schizophrenia. Furthermore, a study of PLC-β1 knockdown in the medial prefrontal cortex of mice has shown a specific behavioral deficit, impaired working memory. These results support the notion that disruption of PLC-β1-linked signaling in the brain is strongly involved in the pathogenesis of schizophrenia. In this review, we broadly investigate recent studies regarding schizophrenia-related behaviors as well as their various clinical and biological correlates in PLC-β1<sup>−/−</sup> and knockdown mouse models. This will provide a better understanding of the pathological relevance of the altered expression of PLC-β1 in the brains of patients with schizophrenia. Evidence accumulated will shed light on future in-depth studies, possibly in human subjects.</p>
</abstract>
<kwd-group>
<kwd>schizophrenia</kwd>
<kwd>PLC-<bold>β</bold>1</kwd>
<kwd>schizophrenia endophenotypes</kwd>
<kwd>mPFC</kwd>
<kwd>DLPFC</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="165"></ref-count>
<page-count count="8"></page-count>
<word-count count="7550"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<sec id="S1-1">
<title>Schizophrenia-Related Phenotypes</title>
<p>Schizophrenia is generally characterized by genetic and neurofunctional abnormalities and classified into three major abnormal symptoms – positive, negative, and cognitive symptoms (<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B6">6</xref>). Positive symptoms are those that are present in people with schizophrenia, such as delusions, hallucinations, thought disorder, and paranoia (<xref ref-type="bibr" rid="B7">7</xref>), whereas negative symptoms are deficits of normal emotional or of other thought processes such as flat affect, avolition, and social withdrawal (<xref ref-type="bibr" rid="B8">8</xref>). Cognitive symptoms refer to the difficulties with concentration and memory; examples include short- and long-term memory deficits as well as deficits in attention, planning, and abstract thinking (<xref ref-type="bibr" rid="B9">9</xref>–<xref ref-type="bibr" rid="B11">11</xref>).</p>
</sec>
<sec id="S1-2">
<title>Pathogenesis of Schizophrenia</title>
<p>The pathogenesis of schizophrenia has been previously reported to arise from specific neuronal abnormalities in several brain regions including prefrontal cortex (PFC) (<xref ref-type="bibr" rid="B12">12</xref>–<xref ref-type="bibr" rid="B14">14</xref>). Neural mechanisms underlying schizophrenia symptoms in several brain areas have been explained by abnormalities in the dopaminergic (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>), serotonergic (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), muscarinic (<xref ref-type="bibr" rid="B19">19</xref>–<xref ref-type="bibr" rid="B22">22</xref>), and glutamatergic signaling (<xref ref-type="bibr" rid="B23">23</xref>–<xref ref-type="bibr" rid="B25">25</xref>). Of the many mechanisms, the phosphoinositide (PI) signaling, one of the major G-protein-linked pathways operating in the central nervous system (CNS), seems to be a point of convergence for all signaling pathways mentioned above (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). PI signaling pathways are impaired in specific brain regions of patients with neurological (<xref ref-type="bibr" rid="B28">28</xref>–<xref ref-type="bibr" rid="B31">31</xref>) and psychiatric disorders (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Altered activity in PI signal pathways has been implicated in impaired cognition, mood, and abnormal behaviors, which is associated with mental disorders including schizophrenia (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
<sec id="S1-3">
<title>PI Signaling</title>
<p>PI signaling involves PI-specific phospholipase C (PLC) (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) to produce a pair of second messengers, diacylglycerol (DAG), and inositol 1,4,5-trisphosphate (IP<sub>3</sub>) (<xref ref-type="bibr" rid="B38">38</xref>). In general, DAG activates protein kinase C (PKC), whereas IP<sub>3</sub> mobilizes Ca<sup>2+</sup> from the intracellular endoplasmic reticulum (ER) stores to the cytoplasm (<xref ref-type="bibr" rid="B39">39</xref>). PLC-β is one of the three subtypes of PLC and is distinguished from PLC-γ and PLC-δ by structure and activation mechanisms (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). PLC-β acts through G protein-dependent pathways, and G<sub>q</sub>/PLC-β pathway is readily activated by specific neurotransmitter receptors such as the M1, M3, and M5 muscarinic acetylcholine receptors (mAChRs), the group 1 and 5 metabotropic glutamate receptors (mGluRs), and the 2A and 2C subtype of serotonergic receptors (5-HT<sub>2A</sub>R and 5-HT<sub>2C</sub>R) (<xref ref-type="bibr" rid="B42">42</xref>–<xref ref-type="bibr" rid="B46">46</xref>). Protein purification and molecular cloning have identified four PLC-β isoforms: PLC-β1, PLC-β2, PLC-β3, and PLC-β4 (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Interestingly, each PLC-β isoenzyme has a unique distribution pattern in the brain (<xref ref-type="bibr" rid="B49">49</xref>). PLC-β1 expression is relatively abundant in the cerebral cortex although it is widely distributed in many brain areas (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B49">49</xref>). PLC-β2 is mainly expressed in the white matter, indicating that its expression is in non-neuronal cells (<xref ref-type="bibr" rid="B49">49</xref>). PLC-β3 expression is very low throughout the brain (<xref ref-type="bibr" rid="B50">50</xref>). Finally, PLC-β4 is highly expressed in the cerebellum and medial septum but is almost negligible in the hippocampus (<xref ref-type="bibr" rid="B49">49</xref>–<xref ref-type="bibr" rid="B51">51</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Phospholipase C signaling in neuronal cells</bold>. Phospholipase C (PLC) cleaves phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>), a membrane phospholipid, to generate two second messengers, inositol 1,4,5-trisphosphate (IP<sub>3</sub>) and diacylglycerol (DAG). IP<sub>3</sub> is water soluble, diffusing through the cytosol to bind to and open a ligand-gated Ca<sup>2+</sup> channel, such as ryanodine receptor (RyR) in the endoplasmic reticulum (ER). Thus, stimulation of a receptor (R) linked to this G-alpha (G) is a way to increase Ca<sup>2+</sup> inside the cytosol. DAG is lipid soluble and stays in the membrane. It activates protein kinase C (PKC), which, like protein kinase A (PKA), phosphorylates particular target proteins.</p>
</caption>
<graphic xlink:href="fpsyt-06-00159-g001"></graphic>
</fig>
<p>Abnormal PLC-β1 expression has been detected in the brains of patients with schizophrenia (<xref ref-type="bibr" rid="B52">52</xref>–<xref ref-type="bibr" rid="B54">54</xref>). A decrease of PLC-β1 expression in the dorsolateral prefrontal cortex (DLPFC) of the brains of patients with schizophrenia might account for the possible pathogenic involvement of PLC-β1 in schizophrenia patients (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>In this review, PLC-β1 signaling pathways, especially their hypofunction will be discussed in relation to the pathogenesis of schizophrenia-like symptoms in the rodent medial prefrontal cortex (mPFC) as well as their hypofunction in patients with schizophrenia associated with human DLPFC.</p>
</sec>
</sec>
<sec id="S2">
<title>PLC-β1 in Schizophrenia Symptoms</title>
<p>The association of the PLC-β1 with schizophrenia symptoms has been addressed by behavioral studies in PLC-β1<sup>−/−</sup> mice (<xref ref-type="bibr" rid="B55">55</xref>–<xref ref-type="bibr" rid="B59">59</xref>). It has been well established that schizophrenia-like animal models exhibit hyperlocomotion (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B60">60</xref>–<xref ref-type="bibr" rid="B64">64</xref>). In the open-field test, for example, PLC–β1<sup>−/−</sup> mice have shown an increase in locomotor activity (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>), a phenotype which was also exhibited in mice with a defect in PLC–β1-relevant signaling. For instance, M1 mAChR knockout results in hyperlocomotion in mice (<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>), whereas mice lacking M3 and M5 mAChRs show normal locomotor activity (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>).</p>
<p>Abnormal social behaviors are regarded as one of the negative symptoms in schizophrenia patients. In mice, barbering behavior, also known as whisker trimming, seems to reflect a cooperative social activity and social dominance (<xref ref-type="bibr" rid="B67">67</xref>). Interestingly, PLC–β1<sup>−/−</sup> mice show a deficit in barbering behaviors, suggesting that PLC–β1 signaling is required for normal social interaction and dominance (<xref ref-type="bibr" rid="B56">56</xref>). In addition, the relevance of the lack of nesting behaviors to negative symptoms in patients with schizophrenia has been demonstrated (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Nest building in mice may represent activities of daily living (<xref ref-type="bibr" rid="B70">70</xref>) and a cooperative activity in rodent social behavior (<xref ref-type="bibr" rid="B68">68</xref>). Deficits in nest building are related to self-neglect (<xref ref-type="bibr" rid="B56">56</xref>) and social withdrawal (<xref ref-type="bibr" rid="B71">71</xref>). PLC–β1<sup>−/−</sup> mice also display significant nesting deficits, addressing negative-like symptoms in rodents.</p>
<p>The lack of sociability is also regarded as a negative symptom in schizophrenia patients (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>). A three-chamber procedure was previously used to evaluate sociability by assessing the time spent in each chamber of three divided areas. One area contains a conspecific, but the other area does not. If a mouse spends more time in the chamber with a conspecific, it has higher sociability (<xref ref-type="bibr" rid="B74">74</xref>). This procedure has been complemented by measuring sniffing time because sniffing time is more accurate than time in chamber when evaluating sociability (<xref ref-type="bibr" rid="B59">59</xref>). The total sniffing time around either a mouse or an object was scored. If the time spent sniffing around an unfamiliar conspecific was greater than an inanimate object, this is indicative of higher sociability. PLC-β1<sup>+/+</sup> mice showed normal sociability as they spent more time sniffing around an unfamiliar conspecific than an inanimate object. On the contrary, sniffing time around both a conspecific and inanimate object was decreased in PLC-β1<sup>−/−</sup> mice. Consequently, PLC-β1<sup>−/−</sup> mice have lost their interest in the novelty of an unfamiliar conspecific, demonstrating impaired sociability (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>Cognitive impairment is a core feature of three abnormal symptoms that contribute to the morbidity of schizophrenia. Of cognitive symptoms, sensorimotor gating is essentially a protection mechanism against sensory information overload (<xref ref-type="bibr" rid="B75">75</xref>). A disruption of prepulse inhibition (PPI) is a frequently used translational model of abnormal sensorimotor gating (<xref ref-type="bibr" rid="B76">76</xref>). The PPI deficits have been detected in some neuropsychiatric disorders including schizophrenia (<xref ref-type="bibr" rid="B77">77</xref>–<xref ref-type="bibr" rid="B84">84</xref>). Therefore, PPI may at least in part be predictive of certain cognitive functions in schizophrenia (<xref ref-type="bibr" rid="B84">84</xref>). Furthermore, PLC-β1<sup>−/−</sup> mice also display impaired PPI in acoustic startle response (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Given that schizophrenia patients and PLC-β1<sup>−/−</sup> mice show impairment in PPI, a measure of sensorimotor gating, PLC-β1 signaling pathways seem to be required for normal sensorimotor gating function.</p>
<p>Impaired working memory is considered as a core cognitive deficit in schizophrenia (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>). Delayed non-match to samples (DNMTS) T-maze and Y-maze task have been commonly used to measure working memory function (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>). PLC-β1<sup>−/−</sup> mice exhibit an impairment of working memory in the DNMTS T-maze and Y-maze task (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Based on the working memory deficits in PLC-β1<sup>−/−</sup>, PLC-β1 may be a potential target of pharmaceutical intervention to treat cognitive symptoms in schizophrenia.</p>
</sec>
<sec id="S3">
<title>Human DLPFC and Rodent mPFC</title>
<p>Working memory deficits have been previously reported in a number of neurological and psychiatric disorders including schizophrenia (<xref ref-type="bibr" rid="B89">89</xref>–<xref ref-type="bibr" rid="B91">91</xref>). Previous studies from human behavioral and functional neuroimaging data during working memory tasks have described deteriorated activation of the DLPFC in patients with schizophrenia (<xref ref-type="bibr" rid="B92">92</xref>–<xref ref-type="bibr" rid="B94">94</xref>). The human DLPFC, therefore, is important for the working memory process (<xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B96">96</xref>). Signals associated with working memory are reduced in the DLPFC of patients with schizophrenia (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>). Additionally, deficits in working memory have been shown in human brain injury patients with damage in DLPFC (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). A decrease of both glucose utilization and blood flow during working memory tasks have been observed in the DLPFC of patients with schizophrenia (<xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B101">101</xref>–<xref ref-type="bibr" rid="B104">104</xref>). Using electroencephalography (EEG) during a working memory test, abnormal brain oscillatory activity has been reported in the frontal theta (4–8 Hz) and alpha (8–12 Hz) frequencies in patients with schizophrenia (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>). Human EEG recordings have further revealed abnormal circuitries between the PFC and other brain regions in schizophrenia, such as the temporal lobe and subcortical limbic structures, suggesting that functional connectivity between the PFC and other brain regions play some role in the pathogenesis of schizophrenia (<xref ref-type="bibr" rid="B107">107</xref>–<xref ref-type="bibr" rid="B109">109</xref>). It has been supported by evidence that alterations in synchronized brain oscillation reflect neuronal changes that lead to schizophrenia (<xref ref-type="bibr" rid="B110">110</xref>, <xref ref-type="bibr" rid="B111">111</xref>).</p>
<p>The mouse mPFC is thought to have anatomical and functional homology with the DLPFC in human being (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B112">112</xref>–<xref ref-type="bibr" rid="B114">114</xref>). The mouse mPFC consists of prelimbic (PL) and infralimbic (IL) cortices (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B112">112</xref>–<xref ref-type="bibr" rid="B114">114</xref>). The mouse mPFC receives indirect projections from the dorsal hippocampus (dHPC) and direct afferent inputs from the ventral hippocampus (vHPC) (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>). The mouse mPFC has reciprocal connections with the amygdala and other subcortical limbic structures (<xref ref-type="bibr" rid="B117">117</xref>). Theta frequency synchrony between the mPFC and dHPC, and/or beta (13–30 Hz) frequency synchrony between the mPFC and mediodorsal thalamic nucleus (MD) are required for working memory (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B118">118</xref>).</p>
<p>Both cytotoxic lesions and acute inactivations in the rodent mPFC are able to induce most schizophrenia phenotypes including positive, negative, and cognitive-like symptoms, as well as working memory deficits (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>). It is also worth noting that mPFC deficits represent a key component of the pathophysiology in patients with schizophrenia (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B121">121</xref>).</p>
<p>The shRNA-mediated silencing of PLC-β1 in the mPFC, a mouse model that mimics the decrease of PLC-β1 in the DLPFC of patients with schizophrenia, causes an impairment in working memory (<xref ref-type="bibr" rid="B59">59</xref>). This effect is specific to working memory; mPFC-specific PLC-β1 knockdown does not have an effect on other behaviors relevant to schizophrenia-related endophenotypes characteristic of PLC-β1<sup>−/−</sup> mice, such as locomotion, social behaviors, and sensorimotor gating (<xref ref-type="bibr" rid="B59">59</xref>).</p>
</sec>
<sec id="S4">
<title>PLC-β1 Signaling Pathways Underlying Working Memory in the mPFC</title>
<p>A number of biochemical and genetic studies have demonstrated that modulatory neurotransmission in the PFC is required for cognitive functions including working memory (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B122">122</xref>–<xref ref-type="bibr" rid="B125">125</xref>). Dopaminergic neurotransmission in the PFC has been shown to be important for working memory in both animals and human beings (<xref ref-type="bibr" rid="B126">126</xref>–<xref ref-type="bibr" rid="B134">134</xref>). Regional depletion of PFC dopamine causes profound working memory impairments in monkeys (<xref ref-type="bibr" rid="B126">126</xref>) and rats (<xref ref-type="bibr" rid="B127">127</xref>). Iontophoretic application of dopamine into the PFC for working memory tasks has revealed an increase of delay-period activity in monkeys (<xref ref-type="bibr" rid="B134">134</xref>). During working memory, the dopamine level is transiently increased in the PFC of both rats and human beings (<xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B136">136</xref>). Explained briefly, dopamine receptors are divided into two families (D1 and D2 class) based on second messenger coupling and ligand binding (<xref ref-type="bibr" rid="B137">137</xref>, <xref ref-type="bibr" rid="B138">138</xref>); D1 class, composed of D1 and D5 dopamine receptors, increases the cAMP levels, whereas D2 class, composed of D2, D3, and D4 receptors, decreases cAMP levels (<xref ref-type="bibr" rid="B139">139</xref>, <xref ref-type="bibr" rid="B140">140</xref>). The influence of dopamine in prefrontal neurons is largely mediated by D1 dopamine receptors as they are much more abundant compared to D2 dopamine receptors in PFC pyramidal cells (<xref ref-type="bibr" rid="B141">141</xref>). The PFC D1 dopamine receptors are decreased in patients with schizophrenia (<xref ref-type="bibr" rid="B133">133</xref>). A D1 antagonist is able to suppress PFC delay-period activity. Similarly, the infusion of D1-specific agonists has further confirmed the importance of D1 dopamine receptors in the PFC with improved working memory (<xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B142">142</xref>). Furthermore, the importance of D1 dopamine receptors has been investigated in non-human primates during delayed-response paradigms showing that working memory requires appropriate D1 receptor activation in the DLPFC (<xref ref-type="bibr" rid="B126">126</xref>, <xref ref-type="bibr" rid="B129">129</xref>, <xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B142">142</xref>, <xref ref-type="bibr" rid="B143">143</xref>). Taken together, these observations suggest that altered dopamine transmission at D1 receptors in DLPFC could be involved in the pathophysiology of working memory in schizophrenia (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B145">145</xref>).</p>
<p>In addition to dopamine receptors involved in working memory, other modulatory neurotransmitters, such as norepinephrine (NE) acting through α-adrenergic receptors (<xref ref-type="bibr" rid="B146">146</xref>, <xref ref-type="bibr" rid="B147">147</xref>), serotonin through 5-HT<sub>2A</sub> receptors (<xref ref-type="bibr" rid="B124">124</xref>), and acetylcholine through mAChRs (<xref ref-type="bibr" rid="B148">148</xref>) have been shown to be involved in working memory. Moderate levels of NE activate α<sub>2A</sub> adrenergic receptors and result in improved working memory; however, at higher levels, NE activates α<sub>1</sub> receptors, resulting in impaired working memory (<xref ref-type="bibr" rid="B123">123</xref>, <xref ref-type="bibr" rid="B149">149</xref>, <xref ref-type="bibr" rid="B150">150</xref>). Similarly, it has been proposed that excessive prefrontal NE levels may contribute to the working memory deficits in schizophrenia (<xref ref-type="bibr" rid="B122">122</xref>). Investigation of M1 mAChRs knockout mice has provided evidence that M1 mAChRs are critical for the performance of non-matching-to-sample working memory tasks (<xref ref-type="bibr" rid="B151">151</xref>).</p>
<p>Several lines of research have indirectly indicated that Gq signaling pathways are implicated in working memory (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B130">130</xref>). In detail, translocation of the α subunit of Gq proteins from the membrane to a cytosolic fraction can be used as an indicator of activation (<xref ref-type="bibr" rid="B152">152</xref>). Gq translocates during the delay period of the match-to-place task for working memory (<xref ref-type="bibr" rid="B125">125</xref>), suggesting that the Gq signaling cascade is activated during working memory. Consistently, alterations in prefrontal Gq signalings have been associated with working memory deficits in patients with schizophrenia (<xref ref-type="bibr" rid="B153">153</xref>). RGS4, an inhibitor of Gq protein-induced intracellular Ca<sup>2+</sup> release, is downregulated in PFC of schizophrenia mouse model (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B154">154</xref>).</p>
</sec>
<sec id="S5">
<title>Conclusion and Future Remarks</title>
<p>Although continued investigation is required to fully understand PLC-β1 hypofunction in the pathogenesis of schizophrenia, the results obtained to date suggest some challenges in the treatments for working memory deficits in schizophrenia. As indicated previously, altered expression of PLC-β1 has been detected in several brain regions of patients with schizophrenia including DLPFC (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B155">155</xref>–<xref ref-type="bibr" rid="B158">158</xref>). The major schizophrenia symptoms (<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B6">6</xref>), such as negative and cognitive symptoms, have been observed in the behavioral characterization of PLC-β1<sup>−/−</sup> mice. These results indicate that disrupted PLC-β1 signaling in specific brain regions can be relevant to the pathogenesis of schizophrenia (<xref ref-type="bibr" rid="B55">55</xref>–<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>Furthermore, neurotransmitter transmissions such as dopamine through D1 receptors coupled to PLC in the mPFC (<xref ref-type="bibr" rid="B129">129</xref>, <xref ref-type="bibr" rid="B141">141</xref>, <xref ref-type="bibr" rid="B159">159</xref>, <xref ref-type="bibr" rid="B160">160</xref>), NE acting through α-adrenoreceptors (<xref ref-type="bibr" rid="B146">146</xref>, <xref ref-type="bibr" rid="B147">147</xref>), serotonin through 5-HT<sub>2A</sub> receptors (<xref ref-type="bibr" rid="B124">124</xref>), and acetylcholine through M1 mAChRs (<xref ref-type="bibr" rid="B148">148</xref>) are necessary for working memory. The activities of intracellular second messenger pathways linked with PLC in the mPFC are also critical for working memory (<xref ref-type="bibr" rid="B161">161</xref>–<xref ref-type="bibr" rid="B163">163</xref>). In addition, PLC-β1 knockdown and impaired working memory in the mPFC have been discussed in this review, suggesting that the mPFC-specific PLC-β1 pathways underlying working memory could be different from those for anxiety or other schizophrenia endophenotypes of PLC-β1<sup>−/−</sup> mice (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>In conclusion, these results support the notion that the decrease in PLC-β1 expression in the brains of patients with schizophrenia is a pathogenically relevant molecular marker of the disorder (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B56">56</xref>–<xref ref-type="bibr" rid="B59">59</xref>). This interpretation offers new insight into PLC-β1 hypofunction in the pathogenesis of schizophrenia and may aid in a better understanding of the neural mechanisms underlying working memory deficits in schizophrenia. Finally, PLC-β1 is not detected in a peripheral area (<xref ref-type="bibr" rid="B164">164</xref>, <xref ref-type="bibr" rid="B165">165</xref>). Thus, PLC-β1 KO could not affect obesity or weight gain. PLC-β1 KO mice are even not hypophagic and lean unlike M3 KO mice (<xref ref-type="bibr" rid="B65">65</xref>). Therefore, the PLC-β1-based treatments are necessary for the development of novel psychotherapeutic approaches with reducing metabolic side effects.</p>
</sec>
<sec id="S6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We thank Ms. Arie Kim and Mr. Isaac Kim for their excellent editorial assistance. This work was supported by the Institute for Basic Science (IBS-R001-D1), Korea.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liddle</surname><given-names>PF</given-names></name></person-group>. <article-title>The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy</article-title>. <source/>Br J Psychiatry (<year>1987</year>) <volume>151</volume>:<fpage>145</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1192/bjp.151.2.145</pub-id><pub-id pub-id-type="pmid">3690102</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>TR</given-names></name><name><surname>Liddle</surname><given-names>PF</given-names></name></person-group>
<article-title>Evidence for the validity of negative symptoms</article-title>. <source/>Mod Probl Pharmacopsychiatry (<year>1990</year>) <volume>24</volume>:<fpage>43</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1159/000418012</pub-id><pub-id pub-id-type="pmid">2186268</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>SR</given-names></name><name><surname>Sevy</surname><given-names>S</given-names></name></person-group>. <article-title>Pyramidical model of schizophrenia</article-title>. <source/>Schizophr Bull (<year>1990</year>) <volume>16</volume>:<fpage>537</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1093/schbul/16.3.537</pub-id><pub-id pub-id-type="pmid">2287938</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname><given-names>S</given-names></name><name><surname>Alliger</surname><given-names>RJ</given-names></name><name><surname>Andreasen</surname><given-names>NC</given-names></name></person-group>. <article-title>The distinction of positive and negative symptoms. The failure of a two-dimensional model</article-title>. <source/>Br J Psychiatry (<year>1991</year>) <volume>158</volume>:<fpage>317</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1192/bjp.158.3.317</pub-id><pub-id pub-id-type="pmid">2036528</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzenweger</surname><given-names>MF</given-names></name><name><surname>Dworkin</surname><given-names>RH</given-names></name><name><surname>Wethington</surname><given-names>E</given-names></name></person-group>. <article-title>Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model</article-title>. <source/>Schizophr Bull (<year>1991</year>) <volume>17</volume>:<fpage>515</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1093/schbul/17.3.515</pub-id><pub-id pub-id-type="pmid">1947875</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>NC</given-names></name><name><surname>Arndt</surname><given-names>S</given-names></name><name><surname>Alliger</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Flaum</surname><given-names>M</given-names></name></person-group>. <article-title>Symptoms of schizophrenia. Methods, meanings, and mechanisms</article-title>. <source/>Arch Gen Psychiatry (<year>1995</year>) <volume>52</volume>:<fpage>341</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.1995.03950170015003</pub-id><pub-id pub-id-type="pmid">7726714</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>NC</given-names></name><name><surname>Olsen</surname><given-names>S</given-names></name></person-group>. <article-title>Negative v positive schizophrenia. Definition and validation</article-title>. <source/>Arch Gen Psychiatry (<year>1982</year>) <volume>39</volume>:<fpage>789</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.1982.04290070025006</pub-id><pub-id pub-id-type="pmid">7165478</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>NC</given-names></name></person-group>. <article-title>Negative symptoms in schizophrenia. Definition and reliability</article-title>. <source/>Arch Gen Psychiatry (<year>1982</year>) <volume>39</volume>:<fpage>784</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.1982.04290070020005</pub-id><pub-id pub-id-type="pmid">7165477</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>MF</given-names></name></person-group>. <article-title>What are the functional consequences of neurocognitive deficits in schizophrenia?</article-title>
<source/>Am J Psychiatry (<year>1996</year>) <volume>153</volume>:<fpage>321</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1176/ajp.153.3.321</pub-id><pub-id pub-id-type="pmid">8610818</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname><given-names>TD</given-names></name><name><surname>Glahn</surname><given-names>DC</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Van Erp</surname><given-names>TG</given-names></name><name><surname>Karlsgodt</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>MS</given-names></name><etal></etal></person-group>
<article-title>Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>2005</year>) <volume>62</volume>:<fpage>1071</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.62.10.1071</pub-id><pub-id pub-id-type="pmid">16203952</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesh</surname><given-names>TA</given-names></name><name><surname>Niendam</surname><given-names>TA</given-names></name><name><surname>Minzenberg</surname><given-names>MJ</given-names></name><name><surname>Carter</surname><given-names>CS</given-names></name></person-group>. <article-title>Cognitive control deficits in schizophrenia: mechanisms and meaning</article-title>. <source/>Neuropsychopharmacology (<year>2011</year>) <volume>36</volume>:<fpage>316</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1038/npp.2010.156</pub-id><pub-id pub-id-type="pmid">20844478</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Tellez</surname><given-names>JF</given-names></name><name><surname>Lopez-Aranda</surname><given-names>MF</given-names></name><name><surname>Navarro-Lobato</surname><given-names>I</given-names></name><name><surname>Masmudi-Martin</surname><given-names>M</given-names></name><name><surname>Montanez</surname><given-names>EM</given-names></name><name><surname>Calvo</surname><given-names>EB</given-names></name><etal></etal></person-group>
<article-title>Prefrontal inositol triphosphate is molecular correlate of working memory in nonhuman primates</article-title>. <source/>J Neurosci (<year>2010</year>) <volume>30</volume>:<fpage>3067</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1523/jneurosci.4565-09.2010</pub-id><pub-id pub-id-type="pmid">20181603</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigurdsson</surname><given-names>T</given-names></name><name><surname>Stark</surname><given-names>KL</given-names></name><name><surname>Karayiorgou</surname><given-names>M</given-names></name><name><surname>Gogos</surname><given-names>JA</given-names></name><name><surname>Gordon</surname><given-names>JA</given-names></name></person-group>. <article-title>Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia</article-title>. <source/>Nature (<year>2010</year>) <volume>464</volume>:<fpage>763</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature08855</pub-id><pub-id pub-id-type="pmid">20360742</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name></person-group>. <article-title>Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia</article-title>. <source/>Int J Dev Neurosci (<year>2011</year>) <volume>29</volume>:<fpage>215</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2011.02.006</pub-id><pub-id pub-id-type="pmid">21345366</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeman</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name></person-group>. <article-title>Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons</article-title>. <source/>Science (<year>1975</year>) <volume>188</volume>:<fpage>1217</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1126/science.1145194</pub-id><pub-id pub-id-type="pmid">1145194</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creese</surname><given-names>I</given-names></name><name><surname>Burt</surname><given-names>DR</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group>. <article-title>Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs</article-title>. <source/>Science (<year>1976</year>) <volume>192</volume>:<fpage>481</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1126/science.3854</pub-id><pub-id pub-id-type="pmid">3854</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarr</surname><given-names>E</given-names></name><name><surname>Copolov</surname><given-names>DL</given-names></name><name><surname>Dean</surname><given-names>B</given-names></name></person-group>. <article-title>A proposed pathological model in the hippocampus of subjects with schizophrenia</article-title>. <source/>Clin Exp Pharmacol Physiol (<year>2001</year>) <volume>28</volume>:<fpage>70</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1046/j.1440-1681.2001.03400.x</pub-id><pub-id pub-id-type="pmid">11153541</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Figueroa</surname><given-names>AL</given-names></name><name><surname>Norton</surname><given-names>CS</given-names></name><name><surname>Lopez-Figueroa</surname><given-names>MO</given-names></name><name><surname>Armellini-Dodel</surname><given-names>D</given-names></name><name><surname>Burke</surname><given-names>S</given-names></name><name><surname>Akil</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia</article-title>. <source/>Biol Psychiatry (<year>2004</year>) <volume>55</volume>:<fpage>225</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2003.09.017</pub-id><pub-id pub-id-type="pmid">14744462</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JP</given-names><suffix>Jr</suffix></name><name><surname>Enna</surname><given-names>SJ</given-names></name><name><surname>Bylund</surname><given-names>DB</given-names></name><name><surname>Gillin</surname><given-names>JC</given-names></name><name><surname>Wyatt</surname><given-names>RJ</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group>. <article-title>Neurotransmitter receptors in frontal cortex of schizophrenics</article-title>. <source/>Arch Gen Psychiatry (<year>1979</year>) <volume>36</volume>:<fpage>927</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.1979.01780090013001</pub-id><pub-id pub-id-type="pmid">37813</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Nishikawa</surname><given-names>T</given-names></name><name><surname>Takashima</surname><given-names>M</given-names></name><name><surname>Toru</surname><given-names>M</given-names></name></person-group>. <article-title>Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics</article-title>. <source/>Life Sci (<year>1983</year>) <volume>33</volume>:<fpage>2187</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/0024-3205(83)90290-4</pub-id><pub-id pub-id-type="pmid">6139728</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>B</given-names></name><name><surname>Crook</surname><given-names>JM</given-names></name><name><surname>Opeskin</surname><given-names>K</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Keks</surname><given-names>N</given-names></name><name><surname>Copolov</surname><given-names>DL</given-names></name></person-group>. <article-title>The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia</article-title>. <source/>Mol Psychiatry (<year>1996</year>) <volume>1</volume>:<fpage>54</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">9118315</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raedler</surname><given-names>TJ</given-names></name><name><surname>Bymaster</surname><given-names>FP</given-names></name><name><surname>Tandon</surname><given-names>R</given-names></name><name><surname>Copolov</surname><given-names>D</given-names></name><name><surname>Dean</surname><given-names>B</given-names></name></person-group>. <article-title>Towards a muscarinic hypothesis of schizophrenia</article-title>. <source/>Mol Psychiatry (<year>2007</year>) <volume>12</volume>:<fpage>232</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1038/sj.mp.4001924</pub-id><pub-id pub-id-type="pmid">17146471</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noga</surname><given-names>JT</given-names></name><name><surname>Hyde</surname><given-names>TM</given-names></name><name><surname>Herman</surname><given-names>MM</given-names></name><name><surname>Spurney</surname><given-names>CF</given-names></name><name><surname>Bigelow</surname><given-names>LB</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><etal></etal></person-group>
<article-title>Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains</article-title>. <source/>Synapse (<year>1997</year>) <volume>27</volume>:<fpage>168</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1002/(SICI)1098-2396(199711)27:3&lt;168::AID-SYN2&gt;3.3.CO;2-#</pub-id><pub-id pub-id-type="pmid">9329152</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohnuma</surname><given-names>T</given-names></name><name><surname>Augood</surname><given-names>SJ</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Mckenna</surname><given-names>PJ</given-names></name><name><surname>Emson</surname><given-names>PC</given-names></name></person-group>. <article-title>Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia</article-title>. <source/>Brain Res Mol Brain Res (<year>1998</year>) <volume>56</volume>:<fpage>207</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/S0169-328X(98)00063-1</pub-id><pub-id pub-id-type="pmid">9602129</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nudmamud-Thanoi</surname><given-names>S</given-names></name><name><surname>Reynolds</surname><given-names>GP</given-names></name></person-group>. <article-title>The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders</article-title>. <source/>Neurosci Lett (<year>2004</year>) <volume>372</volume>:<fpage>173</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2004.09.035</pub-id><pub-id pub-id-type="pmid">15531111</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moolenaar</surname><given-names>WH</given-names></name></person-group>
<article-title>G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation</article-title>. <source/>Cell Growth Differ (<year>1991</year>) <volume>2</volume>:<fpage>359</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">1664236</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SJ</given-names></name><name><surname>Chae</surname><given-names>HZ</given-names></name><name><surname>Rhee</surname><given-names>SG</given-names></name><name><surname>Exton</surname><given-names>JH</given-names></name></person-group>. <article-title>Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins</article-title>. <source/>Nature (<year>1991</year>) <volume>350</volume>:<fpage>516</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/350516a0</pub-id><pub-id pub-id-type="pmid">1707501</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubeau</surname><given-names>F</given-names></name><name><surname>Sherwin</surname><given-names>A</given-names></name><name><surname>Olivier</surname><given-names>A</given-names></name><name><surname>Villemure</surname><given-names>J</given-names></name><name><surname>Leblanc</surname><given-names>R</given-names></name><name><surname>Quesney</surname><given-names>LF</given-names></name><etal></etal></person-group>
<article-title>Excitatory amino acids modulate phosphoinositide signal transduction in human epileptic neocortex</article-title>. <source/>Epilepsia (<year>1992</year>) <volume>33</volume>:<fpage>255</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1111/j.1528-1157.1992.tb02314.x</pub-id><pub-id pub-id-type="pmid">1312458</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>MA</given-names></name><name><surname>Claro</surname><given-names>E</given-names></name></person-group>. <article-title>Transmembrane signaling through phospholipase C in human cortical membranes</article-title>. <source/>Neurochem Res (<year>1993</year>) <volume>18</volume>:<fpage>139</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1007/BF01474676</pub-id><pub-id pub-id-type="pmid">8386329</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>AF</given-names></name><name><surname>Powers</surname><given-names>RE</given-names></name><name><surname>Jope</surname><given-names>RS</given-names></name></person-group>. <article-title>Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer’s disease</article-title>. <source/>Neuroscience (<year>1995</year>) <volume>69</volume>:<fpage>125</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/0306-4522(95)00220-D</pub-id><pub-id pub-id-type="pmid">8637611</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimohama</surname><given-names>S</given-names></name><name><surname>Fujimoto</surname><given-names>S</given-names></name><name><surname>Matsushima</surname><given-names>H</given-names></name><name><surname>Takenawa</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Alteration of phospholipase C-delta protein level and specific activity in Alzheimer’s disease</article-title>. <source/>J Neurochem (<year>1995</year>) <volume>64</volume>:<fpage>2629</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1046/j.1471-4159.1995.64062629.x</pub-id><pub-id pub-id-type="pmid">7760043</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>MA</given-names></name><name><surname>Stockmeier</surname><given-names>C</given-names></name><name><surname>Meltzer</surname><given-names>HY</given-names></name><name><surname>Overholser</surname><given-names>JC</given-names></name><name><surname>Dilley</surname><given-names>GE</given-names></name><name><surname>Jope</surname><given-names>RS</given-names></name></person-group>. <article-title>Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain</article-title>. <source/>Brain Res (<year>1996</year>) <volume>723</volume>:<fpage>37</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/0006-8993(96)00207-7</pub-id><pub-id pub-id-type="pmid">8813380</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jope</surname><given-names>RS</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Powers</surname><given-names>RE</given-names></name></person-group>. <article-title>Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer’s disease brain</article-title>. <source/>Neurobiol Aging (<year>1997</year>) <volume>18</volume>:<fpage>111</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/S0197-4580(96)00205-9</pub-id><pub-id pub-id-type="pmid">8983039</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>JK</given-names></name><name><surname>Yasaei</surname><given-names>P</given-names></name><name><surname>Van Kammen</surname><given-names>DP</given-names></name></person-group>. <article-title>Increased turnover of platelet phosphatidylinositol in schizophrenia</article-title>. <source/>Prostaglandins Leukot Essent Fatty Acids (<year>1992</year>) <volume>46</volume>:<fpage>39</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1016/0952-3278(92)90057-P</pub-id><pub-id pub-id-type="pmid">1352896</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNamara</surname><given-names>RK</given-names></name><name><surname>Ostrander</surname><given-names>M</given-names></name><name><surname>Abplanalp</surname><given-names>W</given-names></name><name><surname>Richtand</surname><given-names>NM</given-names></name><name><surname>Benoit</surname><given-names>SC</given-names></name><name><surname>Clegg</surname><given-names>DJ</given-names></name></person-group>. <article-title>Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness</article-title>. <source/>Prostaglandins Leukot Essent Fatty Acids (<year>2006</year>) <volume>75</volume>:<fpage>237</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1016/j.plefa.2006.07.009</pub-id><pub-id pub-id-type="pmid">16935483</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>CF</given-names></name><name><surname>Balcarek</surname><given-names>JM</given-names></name><name><surname>Varrichio</surname><given-names>A</given-names></name><name><surname>Crooke</surname><given-names>ST</given-names></name></person-group>. <article-title>Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C</article-title>. <source/>Nature (<year>1988</year>) <volume>334</volume>:<fpage>268</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/334268a0</pub-id><pub-id pub-id-type="pmid">3398923</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crooke</surname><given-names>ST</given-names></name><name><surname>Bennett</surname><given-names>CF</given-names></name></person-group>. <article-title>Mammalian phosphoinositide-specific phospholipase C isoenzymes</article-title>. <source/>Cell Calcium (<year>1989</year>) <volume>10</volume>:<fpage>309</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/0143-4160(89)90057-2</pub-id><pub-id pub-id-type="pmid">2548725</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Exton</surname><given-names>JH</given-names></name></person-group>. <article-title>Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins</article-title>. <source/>Annu Rev Pharmacol Toxicol (<year>1996</year>) <volume>36</volume>:<fpage>481</fpage>–<lpage>509</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.pa.36.040196.002405</pub-id><pub-id pub-id-type="pmid">8725399</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishizuka</surname><given-names>Y</given-names></name></person-group>. <article-title>The molecular heterogeneity of protein kinase C and its implications for cellular regulation</article-title>. <source/>Nature (<year>1988</year>) <volume>334</volume>:<fpage>661</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/334661a0</pub-id><pub-id pub-id-type="pmid">3045562</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>PG</given-names></name><name><surname>Ryu</surname><given-names>SH</given-names></name><name><surname>Moon</surname><given-names>KH</given-names></name><name><surname>Suh</surname><given-names>HW</given-names></name><name><surname>Rhee</surname><given-names>SG</given-names></name></person-group>. <article-title>Cloning and sequence of multiple forms of phospholipase C</article-title>. <source/>Cell (<year>1988</year>) <volume>54</volume>:<fpage>161</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/0092-8674(88)90548-X</pub-id><pub-id pub-id-type="pmid">3390863</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhon</surname><given-names>DY</given-names></name><name><surname>Lee</surname><given-names>HH</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Yoo</surname><given-names>OJ</given-names></name><etal></etal></person-group>
<article-title>Cloning, sequencing, purification, and Gq-dependent activation of phospholipase C-beta 3</article-title>. <source/>J Biol Chem (<year>1993</year>) <volume>268</volume>:<fpage>6654</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">8454637</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>HR</given-names></name><name><surname>Wallace</surname><given-names>MA</given-names></name><name><surname>Fain</surname><given-names>JN</given-names></name></person-group>. <article-title>Activation of phospholipase C in rabbit brain membranes by carbachol in the presence of GTP gamma S; effects of biological detergents</article-title>. <source/>Biochim Biophys Acta (<year>1990</year>) <volume>1054</volume>:<fpage>129</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1016/0167-4889(90)90214-X</pub-id><pub-id pub-id-type="pmid">2166590</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutkind</surname><given-names>JS</given-names></name><name><surname>Novotny</surname><given-names>EA</given-names></name><name><surname>Brann</surname><given-names>MR</given-names></name><name><surname>Robbins</surname><given-names>KC</given-names></name></person-group>. <article-title>Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes</article-title>. <source/>Proc Natl Acad Sci U S A (<year>1991</year>) <volume>88</volume>:<fpage>4703</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.88.11.4703</pub-id><pub-id pub-id-type="pmid">1905013</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salles</surname><given-names>J</given-names></name><name><surname>Wallace</surname><given-names>MA</given-names></name><name><surname>Fain</surname><given-names>JN</given-names></name></person-group>. <article-title>Modulation of the phospholipase C activity in rat brain cortical membranes by simultaneous activation of distinct monoaminergic and cholinergic muscarinic receptors</article-title>. <source/>Brain Res Mol Brain Res (<year>1993</year>) <volume>20</volume>:<fpage>111</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/0169-328X(93)90115-6</pub-id><pub-id pub-id-type="pmid">8255172</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Jun</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Kang</surname><given-names>NG</given-names></name><name><surname>Min</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><etal></etal></person-group>
<article-title>Phospholipase C isozymes selectively couple to specific neurotransmitter receptors</article-title>. <source/>Nature (<year>1997</year>) <volume>389</volume>:<fpage>290</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1038/38508</pub-id><pub-id pub-id-type="pmid">9305844</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>AJ</given-names></name><name><surname>Blakemore</surname><given-names>C</given-names></name><name><surname>Katsnelson</surname><given-names>A</given-names></name><name><surname>Vitalis</surname><given-names>T</given-names></name><name><surname>Huber</surname><given-names>KM</given-names></name><name><surname>Bear</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex</article-title>. <source/>Nat Neurosci (<year>2001</year>) <volume>4</volume>:<fpage>282</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/85132</pub-id><pub-id pub-id-type="pmid">11224545</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Park</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>CG</given-names></name><name><surname>Rhee</surname><given-names>SG</given-names></name></person-group>. <article-title>Purification, molecular cloning, and sequencing of phospholipase C-beta 4</article-title>. <source/>J Biol Chem (<year>1993</year>) <volume>268</volume>:<fpage>21318</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">8407970</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>SG</given-names></name><name><surname>Bae</surname><given-names>YS</given-names></name></person-group>
<article-title>Regulation of phosphoinositide-specific phospholipase C isozymes</article-title>. <source/>J Biol Chem (<year>1997</year>) <volume>272</volume>:<fpage>15045</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.272.24.15045</pub-id><pub-id pub-id-type="pmid">9182519</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Kano</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name></person-group>
<article-title>Patterns of expression for the mRNA corresponding to the four isoforms of PLCb in mouse brain</article-title>. <source/>Eur J Neurosci (<year>1998</year>) <volume>10</volume>(<issue>6</issue>):<fpage>2016</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1046/j.1460-9568.1998.00213.x</pub-id><pub-id pub-id-type="pmid">9753089</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>O</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name></person-group>. <article-title>Localization of mRNAs for three novel members (beta 3, beta 4 and gamma 2) of phospholipase C family in mature rat brain</article-title>. <source/>Neurosci Lett (<year>1994</year>) <volume>182</volume>:<fpage>17</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/0304-3940(94)90194-5</pub-id><pub-id pub-id-type="pmid">7891878</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Gireesh</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><etal></etal></person-group>
<article-title>Phospholipase C beta 4 in the medial septum controls cholinergic theta oscillations and anxiety behaviors</article-title>. <source/>J Neurosci (<year>2009</year>) <volume>29</volume>:<fpage>15375</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1523/jneurosci.3126-09.2009</pub-id><pub-id pub-id-type="pmid">20007462</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>XH</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Shirakawa</surname><given-names>O</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name></person-group>. <article-title>Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia</article-title>. <source/>Biol Psychiatry (<year>1999</year>) <volume>46</volume>:<fpage>1665</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(99)00036-0</pub-id><pub-id pub-id-type="pmid">10624548</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirakawa</surname><given-names>O</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>XH</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name></person-group>. <article-title>Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2001</year>) <volume>25</volume>:<fpage>867</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/S0278-5846(01)00149-X</pub-id><pub-id pub-id-type="pmid">11383982</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udawela</surname><given-names>M</given-names></name><name><surname>Scarr</surname><given-names>E</given-names></name><name><surname>Hannan</surname><given-names>AJ</given-names></name><name><surname>Thomas</surname><given-names>EA</given-names></name><name><surname>Dean</surname><given-names>B</given-names></name></person-group>. <article-title>Phospholipase C beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness</article-title>. <source/>Aust N Z J Psychiatry (<year>2011</year>) <volume>45</volume>:<fpage>140</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3109/00048674.2010.533364</pub-id><pub-id pub-id-type="pmid">21091263</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>RK</given-names></name><name><surname>Shin</surname><given-names>HS</given-names></name></person-group>. <article-title>Genetic dissection of theta rhythm heterogeneity in mice</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2005</year>) <volume>102</volume>:<fpage>18165</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0505498102</pub-id><pub-id pub-id-type="pmid">16330775</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>HS</given-names></name></person-group>
<article-title>Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cbeta1</article-title>. <source/>Genes Brain Behav (<year>2007</year>) <volume>7</volume>:<fpage>120</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00351.x</pub-id><pub-id pub-id-type="pmid">17696993</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McOmish</surname><given-names>CE</given-names></name><name><surname>Burrows</surname><given-names>E</given-names></name><name><surname>Howard</surname><given-names>M</given-names></name><name><surname>Scarr</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Shin</surname><given-names>HS</given-names></name><etal></etal></person-group>
<article-title>Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration</article-title>. <source/>Mol Psychiatry (<year>2008</year>) <volume>13</volume>:<fpage>661</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1038/sj.mp.4002046</pub-id><pub-id pub-id-type="pmid">17667964</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McOmish</surname><given-names>CE</given-names></name><name><surname>Burrows</surname><given-names>EL</given-names></name><name><surname>Howard</surname><given-names>M</given-names></name><name><surname>Hannan</surname><given-names>AJ</given-names></name></person-group>
<article-title>PLC-beta1 knockout mice as a model of disrupted cortical development and plasticity: behavioral endophenotypes and dysregulation of RGS4 gene expression</article-title>. <source/>Hippocampus (<year>2008</year>) <volume>18</volume>:<fpage>824</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1002/hipo.20443</pub-id><pub-id pub-id-type="pmid">18493969</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Koh</surname><given-names>HY</given-names></name><etal></etal></person-group>
<article-title>Knockdown of phospholipase C-beta1 in the medial prefrontal cortex of male mice impairs working memory among multiple schizophrenia endophenotypes</article-title>. <source/>J Psychiatry Neurosci (<year>2015</year>) <volume>40</volume>:<fpage>78</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1503/jpn.130285</pub-id><pub-id pub-id-type="pmid">25268789</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>NC</given-names></name><name><surname>Flaum</surname><given-names>M</given-names></name><name><surname>Swayze</surname><given-names>VW</given-names><suffix>II</suffix></name><name><surname>Tyrrell</surname><given-names>G</given-names></name><name><surname>Arndt</surname><given-names>S</given-names></name></person-group>. <article-title>Positive and negative symptoms in schizophrenia. A critical reappraisal</article-title>. <source/>Arch Gen Psychiatry (<year>1990</year>) <volume>47</volume>:<fpage>615</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.1990.01810190015002</pub-id><pub-id pub-id-type="pmid">2360855</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>NC</given-names></name></person-group>
<article-title>Symptoms, signs, and diagnosis of schizophrenia</article-title>. <source/>Lancet (<year>1995</year>) <volume>346</volume>:<fpage>477</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(95)91325-4</pub-id><pub-id pub-id-type="pmid">7637483</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>A</given-names></name></person-group>. <article-title>A paradigm shift in brain research</article-title>. <source/>Science (<year>2001</year>) <volume>294</volume>:<fpage>1021</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1126/science.1066969</pub-id><pub-id pub-id-type="pmid">11691978</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>DJ</given-names></name><name><surname>Sotnikova</surname><given-names>TD</given-names></name><name><surname>Gainetdinov</surname><given-names>RR</given-names></name><name><surname>Huang</surname><given-names>SY</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group>. <article-title>Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2001</year>) <volume>98</volume>:<fpage>15312</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.261583798</pub-id><pub-id pub-id-type="pmid">11752469</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Duttaroy</surname><given-names>A</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name></person-group>. <article-title>Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor</article-title>. <source/>J Neurosci (<year>2001</year>) <volume>21</volume>:<fpage>5239</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">11438599</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Duttaroy</surname><given-names>A</given-names></name><name><surname>Yamanaka</surname><given-names>A</given-names></name><name><surname>Moriguchi</surname><given-names>T</given-names></name><name><surname>Makita</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean</article-title>. <source/>Nature (<year>2001</year>) <volume>410</volume>:<fpage>207</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1038/35065604</pub-id><pub-id pub-id-type="pmid">11242080</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>M</given-names></name><name><surname>Wortwein</surname><given-names>G</given-names></name><name><surname>Fink-Jensen</surname><given-names>A</given-names></name><name><surname>Woldbye</surname><given-names>DP</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Caine</surname><given-names>SB</given-names></name></person-group>. <article-title>Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice</article-title>. <source/>Psychopharmacology (Berl) (<year>2007</year>) <volume>192</volume>:<fpage>97</fpage>–<lpage>110</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-006-0682-y</pub-id><pub-id pub-id-type="pmid">17310388</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strozik</surname><given-names>E</given-names></name><name><surname>Festing</surname><given-names>MF</given-names></name></person-group>
<article-title>Whisker trimming in mice</article-title>. <source/>Lab Anim (<year>1981</year>) <volume>15</volume>:<fpage>309</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1258/002367781780953040</pub-id><pub-id pub-id-type="pmid">7341838</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>JN</given-names></name></person-group>. <article-title>Designing mouse behavioral tasks relevant to autistic-like behaviors</article-title>. <source/>Ment Retard Dev Disabil Res Rev (<year>2004</year>) <volume>10</volume>:<fpage>248</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1002/mrdd.20039</pub-id><pub-id pub-id-type="pmid">15666335</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahata</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name></person-group>. <article-title>[Neural mechanism underlying autistic savant and acquired savant syndrome]</article-title>. <source/>Brain Nerve (<year>2008</year>) <volume>60</volume>:<fpage>861</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">18646626</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Schmitt</surname><given-names>F</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Bennett</surname><given-names>D</given-names></name></person-group>. <article-title>Detailed assessment of activities of daily living in moderate to severe Alzheimer’s disease</article-title>. <source/>J Int Neuropsychol Soc (<year>2005</year>) <volume>11</volume>:<fpage>446</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1017/S1355617705050502</pub-id><pub-id pub-id-type="pmid">16209425</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>CM</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name></person-group>. <article-title>Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?</article-title>
<source/>Biol Psychiatry (<year>2006</year>) <volume>59</volume>:<fpage>1198</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.05.008</pub-id><pub-id pub-id-type="pmid">16797265</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>NG</given-names></name><name><surname>Ponzoha</surname><given-names>CA</given-names></name><name><surname>Cutler</surname><given-names>DL</given-names></name><name><surname>Weigel</surname><given-names>RM</given-names></name></person-group>. <article-title>Social networks and negative versus positive symptoms of schizophrenia</article-title>. <source/>Schizophr Bull (<year>1989</year>) <volume>15</volume>:<fpage>625</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1093/schbul/15.4.625</pub-id><pub-id pub-id-type="pmid">2623442</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellack</surname><given-names>AS</given-names></name><name><surname>Morrison</surname><given-names>RL</given-names></name><name><surname>Wixted</surname><given-names>JT</given-names></name><name><surname>Mueser</surname><given-names>KT</given-names></name></person-group>. <article-title>An analysis of social competence in schizophrenia</article-title>. <source/>Br J Psychiatry (<year>1990</year>) <volume>156</volume>:<fpage>809</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1192/bjp.156.6.809</pub-id><pub-id pub-id-type="pmid">2207511</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moy</surname><given-names>SS</given-names></name><name><surname>Nadler</surname><given-names>JJ</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Barbaro</surname><given-names>RP</given-names></name><name><surname>Johns</surname><given-names>JM</given-names></name><name><surname>Magnuson</surname><given-names>TR</given-names></name><etal></etal></person-group>
<article-title>Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice</article-title>. <source/>Genes Brain Behav (<year>2004</year>) <volume>3</volume>:<fpage>287</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1111/j.1601-1848.2004.00076.x</pub-id><pub-id pub-id-type="pmid">15344922</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Krebs-Thomson</surname><given-names>K</given-names></name><name><surname>Braff</surname><given-names>DL</given-names></name><name><surname>Swerdlow</surname><given-names>NR</given-names></name></person-group>. <article-title>Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review</article-title>. <source/>Psychopharmacology (Berl) (<year>2001</year>) <volume>156</volume>:<fpage>117</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1007/s002130100811</pub-id><pub-id pub-id-type="pmid">11549216</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turetsky</surname><given-names>BI</given-names></name><name><surname>Calkins</surname><given-names>ME</given-names></name><name><surname>Light</surname><given-names>GA</given-names></name><name><surname>Olincy</surname><given-names>A</given-names></name><name><surname>Radant</surname><given-names>AD</given-names></name><name><surname>Swerdlow</surname><given-names>NR</given-names></name></person-group>. <article-title>Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures</article-title>. <source/>Schizophr Bull (<year>2007</year>) <volume>33</volume>:<fpage>69</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1093/schbul/sbl060</pub-id><pub-id pub-id-type="pmid">17135482</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Benbow</surname><given-names>CH</given-names></name><name><surname>Zisook</surname><given-names>S</given-names></name><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Braff</surname><given-names>DL</given-names></name></person-group>
<article-title>A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder</article-title>. <source/>Biol Psychiatry (<year>1993</year>) <volume>33</volume>:<fpage>298</fpage>–<lpage>301</lpage>.<pub-id pub-id-type="doi">10.1016/0006-3223(93)90300-3</pub-id><pub-id pub-id-type="pmid">8471686</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Paulsen</surname><given-names>J</given-names></name><name><surname>Braff</surname><given-names>DL</given-names></name><name><surname>Butters</surname><given-names>N</given-names></name><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Swenson</surname><given-names>MR</given-names></name></person-group>. <article-title>Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington’s disease</article-title>. <source/>J Neurol Neurosurg Psychiatry (<year>1995</year>) <volume>58</volume>:<fpage>192</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.58.2.192</pub-id><pub-id pub-id-type="pmid">7876851</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braff</surname><given-names>DL</given-names></name><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Swerdlow</surname><given-names>NR</given-names></name></person-group>. <article-title>Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies</article-title>. <source/>Psychopharmacology (Berl) (<year>2001</year>) <volume>156</volume>:<fpage>234</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1007/s002130100810</pub-id><pub-id pub-id-type="pmid">11549226</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>W</given-names></name><name><surname>Minassian</surname><given-names>A</given-names></name><name><surname>Feifel</surname><given-names>D</given-names></name><name><surname>Braff</surname><given-names>DL</given-names></name></person-group>. <article-title>Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania</article-title>. <source/>Biol Psychiatry (<year>2001</year>) <volume>50</volume>:<fpage>418</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(01)01184-2</pub-id><pub-id pub-id-type="pmid">11566158</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Karban</surname><given-names>B</given-names></name><name><surname>Ploum</surname><given-names>Y</given-names></name><name><surname>Sharp</surname><given-names>R</given-names></name><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Eastvold</surname><given-names>A</given-names></name></person-group>. <article-title>Tactile prepuff inhibition of startle in children with Tourette’s syndrome: in search of an “fMRI-friendly” startle paradigm</article-title>. <source/>Biol Psychiatry (<year>2001</year>) <volume>50</volume>:<fpage>578</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(01)01164-7</pub-id><pub-id pub-id-type="pmid">11690592</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludewig</surname><given-names>S</given-names></name><name><surname>Ludewig</surname><given-names>K</given-names></name><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Hell</surname><given-names>D</given-names></name><name><surname>Vollenweider</surname><given-names>FX</given-names></name></person-group>. <article-title>Prepulse inhibition deficits in patients with panic disorder</article-title>. <source/>Depress Anxiety (<year>2002</year>) <volume>15</volume>:<fpage>55</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1002/da.10026</pub-id><pub-id pub-id-type="pmid">11891993</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>W</given-names></name><name><surname>Minassian</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>B</given-names></name><name><surname>Maron</surname><given-names>L</given-names></name><name><surname>Lincoln</surname><given-names>A</given-names></name></person-group>. <article-title>Sensorimotor gating deficits in adults with autism</article-title>. <source/>Biol Psychiatry (<year>2007</year>) <volume>61</volume>:<fpage>482</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.09.025</pub-id><pub-id pub-id-type="pmid">16460695</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Weber</surname><given-names>M</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Light</surname><given-names>GA</given-names></name><name><surname>Braff</surname><given-names>DL</given-names></name></person-group>. <article-title>Realistic expectations of prepulse inhibition in translational models for schizophrenia research</article-title>. <source/>Psychopharmacology (Berl) (<year>2008</year>) <volume>199</volume>:<fpage>331</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-008-1072-4</pub-id><pub-id pub-id-type="pmid">18568339</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elvevag</surname><given-names>B</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name></person-group>. <article-title>Cognitive impairment in schizophrenia is the core of the disorder</article-title>. <source/>Crit Rev Neurobiol (<year>2000</year>) <volume>14</volume>:<fpage>1</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1615/CritRevNeurobiol.v14.i1.10</pub-id><pub-id pub-id-type="pmid">11253953</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanlon</surname><given-names>FM</given-names></name><name><surname>Weisend</surname><given-names>MP</given-names></name><name><surname>Hamilton</surname><given-names>DA</given-names></name><name><surname>Jones</surname><given-names>AP</given-names></name><name><surname>Thoma</surname><given-names>RJ</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia</article-title>. <source/>Schizophr Res (<year>2006</year>) <volume>87</volume>:<fpage>67</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.schres.2006.05.021</pub-id><pub-id pub-id-type="pmid">16844347</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>R</given-names></name><name><surname>Aggleton</surname><given-names>JP</given-names></name></person-group>. <article-title>Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility</article-title>. <source/>Eur J Neurosci (<year>2000</year>) <volume>12</volume>:<fpage>4457</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1046/j.0953-816X.2000.01323.x</pub-id><pub-id pub-id-type="pmid">11122356</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Simpson</surname><given-names>EH</given-names></name><name><surname>Polan</surname><given-names>HJ</given-names></name><name><surname>Malleret</surname><given-names>G</given-names></name><name><surname>Vronskaya</surname><given-names>S</given-names></name><name><surname>Winiger</surname><given-names>V</given-names></name><etal></etal></person-group>
<article-title>Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning</article-title>. <source/>Neuron (<year>2006</year>) <volume>49</volume>:<fpage>603</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuron.2006.01.023</pub-id><pub-id pub-id-type="pmid">16476668</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>RG</given-names></name><name><surname>Baddeley</surname><given-names>AD</given-names></name></person-group>. <article-title>Primary and working memory functioning in Alzheimer-type dementia</article-title>. <source/>J Clin Exp Neuropsychol (<year>1988</year>) <volume>10</volume>:<fpage>279</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1080/01688638808408242</pub-id><pub-id pub-id-type="pmid">3280591</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>Working memory dysfunction in schizophrenia</article-title>. <source/>J Neuropsychiatry Clin Neurosci (<year>1994</year>) <volume>6</volume>:<fpage>348</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1176/jnp.6.4.348</pub-id><pub-id pub-id-type="pmid">7841806</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winograd-Gurvich</surname><given-names>C</given-names></name><name><surname>Fitzgerald</surname><given-names>PB</given-names></name><name><surname>Georgiou-Karistianis</surname><given-names>N</given-names></name><name><surname>Bradshaw</surname><given-names>JL</given-names></name><name><surname>White</surname><given-names>OB</given-names></name></person-group>. <article-title>Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson’s disease</article-title>. <source/>Brain Res Bull (<year>2006</year>) <volume>70</volume>:<fpage>312</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainresbull.2006.06.007</pub-id><pub-id pub-id-type="pmid">17027767</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>HY</given-names></name><name><surname>Sust</surname><given-names>S</given-names></name><name><surname>Buckholtz</surname><given-names>JW</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><etal></etal></person-group>
<article-title>Dysfunctional prefrontal regional specialization and compensation in schizophrenia</article-title>. <source/>Am J Psychiatry (<year>2006</year>) <volume>163</volume>:<fpage>1969</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1176/appi.ajp.163.11.1969</pub-id><pub-id pub-id-type="pmid">17074949</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Snellenberg</surname><given-names>JX</given-names></name></person-group>. <article-title>Working memory and long-term memory deficits in schizophrenia: is there a common substrate?</article-title>
<source/>Psychiatry Res (<year>2009</year>) <volume>174</volume>:<fpage>89</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.pscychresns.2009.04.001</pub-id><pub-id pub-id-type="pmid">19837568</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henseler</surname><given-names>I</given-names></name><name><surname>Falkai</surname><given-names>P</given-names></name><name><surname>Gruber</surname><given-names>O</given-names></name></person-group>. <article-title>Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms</article-title>. <source/>J Psychiatr Res (<year>2010</year>) <volume>44</volume>:<fpage>364</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpsychires.2009.09.003</pub-id><pub-id pub-id-type="pmid">19837416</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>KL</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name><name><surname>Ko</surname><given-names>G</given-names></name><name><surname>Davidson</surname><given-names>M</given-names></name></person-group>. <article-title>Dopamine in schizophrenia: a review and reconceptualization</article-title>. <source/>Am J Psychiatry (<year>1991</year>) <volume>148</volume>:<fpage>1474</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1176/ajp.148.11.1474</pub-id><pub-id pub-id-type="pmid">1681750</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>Mawlawi</surname><given-names>O</given-names></name><name><surname>Lombardo</surname><given-names>I</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><name><surname>Martinez</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Prefrontal dopamine D1 receptors and working memory in schizophrenia</article-title>. <source/>J Neurosci (<year>2002</year>) <volume>22</volume>:<fpage>3708</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">11978847</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EE</given-names></name><name><surname>Jonides</surname><given-names>J</given-names></name></person-group>. <article-title>Working memory: a view from neuroimaging</article-title>. <source/>Cogn Psychol (<year>1997</year>) <volume>33</volume>:<fpage>5</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1006/cogp.1997.0658</pub-id><pub-id pub-id-type="pmid">9212720</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Esposito</surname><given-names>M</given-names></name><name><surname>Postle</surname><given-names>BR</given-names></name></person-group>. <article-title>The dependence of span and delayed-response performance on prefrontal cortex</article-title>. <source/>Neuropsychologia (<year>1999</year>) <volume>37</volume>:<fpage>1303</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/S0028-3932(99)00021-4</pub-id><pub-id pub-id-type="pmid">10530730</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mull</surname><given-names>BR</given-names></name><name><surname>Seyal</surname><given-names>M</given-names></name></person-group>. <article-title>Transcranial magnetic stimulation of left prefrontal cortex impairs working memory</article-title>. <source/>Clin Neurophysiol (<year>2001</year>) <volume>112</volume>:<fpage>1672</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/S1388-2457(01)00606-X</pub-id><pub-id pub-id-type="pmid">11514250</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbey</surname><given-names>AK</given-names></name><name><surname>Koenigs</surname><given-names>M</given-names></name><name><surname>Grafman</surname><given-names>J</given-names></name></person-group>
<article-title>Dorsolateral prefrontal contributions to human working memory</article-title>. <source/>Cortex (<year>2012</year>) <volume>49</volume>:<fpage>1195</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="doi">10.1016/j.cortex.2012.05.022</pub-id><pub-id pub-id-type="pmid">22789779</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingvar</surname><given-names>DH</given-names></name><name><surname>Franzen</surname><given-names>G</given-names></name></person-group>
<article-title>Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia</article-title>. <source/>Acta Psychiatr Scand (<year>1974</year>) <volume>50</volume>:<fpage>425</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1111/j.1600-0447.1974.tb09707.x</pub-id><pub-id pub-id-type="pmid">4423855</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchsbaum</surname><given-names>MS</given-names></name><name><surname>Nuechterlein</surname><given-names>KH</given-names></name><name><surname>Haier</surname><given-names>RJ</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Sicotte</surname><given-names>N</given-names></name><name><surname>Hazlett</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography</article-title>. <source/>Br J Psychiatry (<year>1990</year>) <volume>156</volume>:<fpage>216</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1192/bjp.156.2.216</pub-id><pub-id pub-id-type="pmid">2317626</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honey</surname><given-names>GD</given-names></name><name><surname>Bullmore</surname><given-names>ET</given-names></name><name><surname>Soni</surname><given-names>W</given-names></name><name><surname>Varatheesan</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>SC</given-names></name><name><surname>Sharma</surname><given-names>T</given-names></name></person-group>. <article-title>Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia</article-title>. <source/>Proc Natl Acad Sci U S A (<year>1999</year>) <volume>96</volume>:<fpage>13432</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.96.23.13432</pub-id><pub-id pub-id-type="pmid">10557338</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Miletich</surname><given-names>RS</given-names></name><name><surname>Kohn</surname><given-names>PD</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Carson</surname><given-names>RE</given-names></name><name><surname>Quarantelli</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia</article-title>. <source/>Nat Neurosci (<year>2002</year>) <volume>5</volume>:<fpage>267</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1038/nn804</pub-id><pub-id pub-id-type="pmid">11865311</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmiedt</surname><given-names>C</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name><name><surname>Hildebrandt</surname><given-names>H</given-names></name><name><surname>Basar-Eroglu</surname><given-names>C</given-names></name></person-group>. <article-title>Event-related theta oscillations during working memory tasks in patients with schizophrenia and healthy controls</article-title>. <source/>Brain Res Cogn Brain Res (<year>2005</year>) <volume>25</volume>:<fpage>936</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1016/j.cogbrainres.2005.09.015</pub-id><pub-id pub-id-type="pmid">16289526</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachman</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Yee</surname><given-names>CM</given-names></name><name><surname>Therman</surname><given-names>S</given-names></name><name><surname>Manninen</surname><given-names>M</given-names></name><name><surname>Lonnqvist</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Abnormally high EEG alpha synchrony during working memory maintenance in twins discordant for schizophrenia</article-title>. <source/>Schizophr Res (<year>2008</year>) <volume>103</volume>:<fpage>293</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.schres.2008.04.006</pub-id><pub-id pub-id-type="pmid">18534822</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>JM</given-names></name><name><surname>Mathalon</surname><given-names>DH</given-names></name><name><surname>Whitfield</surname><given-names>S</given-names></name><name><surname>Faustman</surname><given-names>WO</given-names></name><name><surname>Roth</surname><given-names>WT</given-names></name></person-group>. <article-title>Reduced communication between frontal and temporal lobes during talking in schizophrenia</article-title>. <source/>Biol Psychiatry (<year>2002</year>) <volume>51</volume>:<fpage>485</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(01)01335-X</pub-id><pub-id pub-id-type="pmid">11922884</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrie</surname><given-names>SM</given-names></name><name><surname>Buechel</surname><given-names>C</given-names></name><name><surname>Whalley</surname><given-names>HC</given-names></name><name><surname>Frith</surname><given-names>CD</given-names></name><name><surname>Friston</surname><given-names>KJ</given-names></name><name><surname>Johnstone</surname><given-names>EC</given-names></name></person-group>. <article-title>Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations</article-title>. <source/>Biol Psychiatry (<year>2002</year>) <volume>51</volume>:<fpage>1008</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(02)01316-1</pub-id><pub-id pub-id-type="pmid">12062886</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>AS</given-names></name><name><surname>Olsen</surname><given-names>RK</given-names></name><name><surname>Kohn</surname><given-names>PD</given-names></name><name><surname>Brown</surname><given-names>T</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><etal></etal></person-group>
<article-title>Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>2005</year>) <volume>62</volume>:<fpage>379</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.62.4.379</pub-id><pub-id pub-id-type="pmid">15809405</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Gonzalez-Burgos</surname><given-names>G</given-names></name></person-group>. <article-title>Neuroplasticity of neocortical circuits in schizophrenia</article-title>. <source/>Neuropsychopharmacology (<year>2008</year>) <volume>33</volume>:<fpage>141</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1038/sj.npp.1301563</pub-id><pub-id pub-id-type="pmid">17805309</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlhaas</surname><given-names>PJ</given-names></name><name><surname>Roux</surname><given-names>F</given-names></name><name><surname>Singer</surname><given-names>W</given-names></name><name><surname>Haenschel</surname><given-names>C</given-names></name><name><surname>Sireteanu</surname><given-names>R</given-names></name><name><surname>Rodriguez</surname><given-names>E</given-names></name></person-group>. <article-title>The development of neural synchrony reflects late maturation and restructuring of functional networks in humans</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2009</year>) <volume>106</volume>:<fpage>9866</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0900390106</pub-id><pub-id pub-id-type="pmid">19478071</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uylings</surname><given-names>HB</given-names></name><name><surname>van Eden</surname><given-names>CG</given-names></name></person-group>
<article-title>Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans</article-title>. <source/>Prog Brain Res (<year>1990</year>) <volume>85</volume>:<fpage>31</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/S0079-6123(08)62675-8</pub-id><pub-id pub-id-type="pmid">2094901</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>VJ</given-names></name><name><surname>Bowman</surname><given-names>EM</given-names></name></person-group>. <article-title>Rodent models of prefrontal cortical function</article-title>. <source/>Trends Neurosci (<year>2002</year>) <volume>25</volume>:<fpage>340</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1016/S0166-2236(02)02164-1</pub-id><pub-id pub-id-type="pmid">12079756</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uylings</surname><given-names>HB</given-names></name><name><surname>Groenewegen</surname><given-names>HJ</given-names></name><name><surname>Kolb</surname><given-names>B</given-names></name></person-group>. <article-title>Do rats have a prefrontal cortex?</article-title>
<source/>Behav Brain Res (<year>2003</year>) <volume>146</volume>:<fpage>3</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2003.09.028</pub-id><pub-id pub-id-type="pmid">14643455</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoover</surname><given-names>WB</given-names></name><name><surname>Vertes</surname><given-names>RP</given-names></name></person-group>. <article-title>Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat</article-title>. <source/>Brain Struct Funct (<year>2007</year>) <volume>212</volume>:<fpage>149</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1007/s00429-007-0150-4</pub-id><pub-id pub-id-type="pmid">17717690</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parent</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Netoff</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>LL</given-names></name></person-group>. <article-title>Identification of the hippocampal input to medial prefrontal cortex in vitro</article-title>. <source/>Cereb Cortex (<year>2010</year>) <volume>20</volume>:<fpage>393</fpage>–<lpage>403</lpage>.<pub-id pub-id-type="doi">10.1093/cercor/bhp108</pub-id><pub-id pub-id-type="pmid">19515741</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vertes</surname><given-names>RP</given-names></name></person-group>
<article-title>Differential projections of the infralimbic and prelimbic cortex in the rat</article-title>. <source/>Synapse (<year>2004</year>) <volume>51</volume>:<fpage>32</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1002/syn.10279</pub-id><pub-id pub-id-type="pmid">14579424</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parnaudeau</surname><given-names>S</given-names></name><name><surname>O’Neill</surname><given-names>PK</given-names></name><name><surname>Bolkan</surname><given-names>SS</given-names></name><name><surname>Ward</surname><given-names>RD</given-names></name><name><surname>Abbas</surname><given-names>AI</given-names></name><name><surname>Roth</surname><given-names>BL</given-names></name><etal></etal></person-group>
<article-title>Inhibition of mediodorsal thalamus disrupts thalamofrontal connectivity and cognition</article-title>. <source/>Neuron (<year>2013</year>) <volume>77</volume>:<fpage>1151</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuron.2013.01.038</pub-id><pub-id pub-id-type="pmid">23522049</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touzani</surname><given-names>K</given-names></name><name><surname>Puthanveettil</surname><given-names>SV</given-names></name><name><surname>Kandel</surname><given-names>ER</given-names></name></person-group>. <article-title>Consolidation of learning strategies during spatial working memory task requires protein synthesis in the prefrontal cortex</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2007</year>) <volume>104</volume>:<fpage>5632</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0611554104</pub-id><pub-id pub-id-type="pmid">17369358</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikari</surname><given-names>A</given-names></name><name><surname>Topiwala</surname><given-names>MA</given-names></name><name><surname>Gordon</surname><given-names>JA</given-names></name></person-group>. <article-title>Single units in the medial prefrontal cortex with anxiety-related firing patterns are preferentially influenced by ventral hippocampal activity</article-title>. <source/>Neuron (<year>2011</year>) <volume>71</volume>:<fpage>898</fpage>–<lpage>910</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuron.2011.07.027</pub-id><pub-id pub-id-type="pmid">21903082</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barch</surname><given-names>DM</given-names></name><name><surname>Carter</surname><given-names>CS</given-names></name><name><surname>Braver</surname><given-names>TS</given-names></name><name><surname>Sabb</surname><given-names>FW</given-names></name><name><surname>Macdonald</surname><given-names>A</given-names><suffix>III</suffix></name><name><surname>Noll</surname><given-names>DC</given-names></name><etal></etal></person-group>
<article-title>Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>2001</year>) <volume>58</volume>:<fpage>280</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.58.3.280</pub-id><pub-id pub-id-type="pmid">11231835</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>JI</given-names></name><name><surname>Temporini</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>KL</given-names></name></person-group>. <article-title>Pharmacologic strategies for augmenting cognitive performance in schizophrenia</article-title>. <source/>Biol Psychiatry (<year>1999</year>) <volume>45</volume>:<fpage>1</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(98)00287-X</pub-id><pub-id pub-id-type="pmid">9894570</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name></person-group>
<article-title>Through the looking glass: differential noradenergic modulation of prefrontal cortical function</article-title>. <source/>Neural Plast (<year>2000</year>) <volume>7</volume>:<fpage>133</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1155/np.2000.133</pub-id><pub-id pub-id-type="pmid">10709220</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Rao</surname><given-names>SG</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>The physiological role of 5-HT2A receptors in working memory</article-title>. <source/>J Neurosci (<year>2002</year>) <volume>22</volume>:<fpage>2843</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">11923449</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runyan</surname><given-names>JD</given-names></name><name><surname>Dash</surname><given-names>PK</given-names></name></person-group>. <article-title>Distinct prefrontal molecular mechanisms for information storage lasting seconds versus minutes</article-title>. <source/>Learn Mem (<year>2005</year>) <volume>12</volume>:<fpage>232</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1101/lm.92405</pub-id><pub-id pub-id-type="pmid">15930501</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brozoski</surname><given-names>TJ</given-names></name><name><surname>Brown</surname><given-names>RM</given-names></name><name><surname>Rosvold</surname><given-names>HE</given-names></name><name><surname>Goldman</surname><given-names>PS</given-names></name></person-group>. <article-title>Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey</article-title>. <source/>Science (<year>1979</year>) <volume>205</volume>:<fpage>929</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1126/science.112679</pub-id><pub-id pub-id-type="pmid">112679</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>H</given-names></name><name><surname>Scatton</surname><given-names>B</given-names></name><name><surname>Le Moal</surname><given-names>M</given-names></name></person-group>. <article-title>Definitive disruption of spatial delayed alternation in rats after lesions in the ventral mesencephalic tegmentum</article-title>. <source/>Neurosci Lett (<year>1979</year>) <volume>15</volume>:<fpage>319</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/0304-3940(79)96133-0</pub-id><pub-id pub-id-type="pmid">530536</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawaguchi</surname><given-names>T</given-names></name><name><surname>Matsumura</surname><given-names>M</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name></person-group>. <article-title>Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex</article-title>. <source/>Neurosci Res (<year>1988</year>) <volume>5</volume>:<fpage>465</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/0168-0102(88)90030-2</pub-id><pub-id pub-id-type="pmid">3399149</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawaguchi</surname><given-names>T</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>D1 dopamine receptors in prefrontal cortex: involvement in working memory</article-title>. <source/>Science (<year>1991</year>) <volume>251</volume>:<fpage>947</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1126/science.1825731</pub-id><pub-id pub-id-type="pmid">1825731</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawaguchi</surname><given-names>T</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task</article-title>. <source/>J Neurophysiol (<year>1994</year>) <volume>71</volume>:<fpage>515</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">7909839</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>Modulation of memory fields by dopamine D1 receptors in prefrontal cortex</article-title>. <source/>Nature (<year>1995</year>) <volume>376</volume>:<fpage>572</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/376572a0</pub-id><pub-id pub-id-type="pmid">7637804</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>BL</given-names></name><name><surname>Arnsten</surname><given-names>AF</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name><name><surname>Roth</surname><given-names>RH</given-names></name></person-group>. <article-title>Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys</article-title>. <source/>Proc Natl Acad Sci U S A (<year>1996</year>) <volume>93</volume>:<fpage>1325</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.93.3.1325</pub-id><pub-id pub-id-type="pmid">8577763</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>Y</given-names></name><name><surname>Suhara</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>O</given-names></name><name><surname>Terasaki</surname><given-names>O</given-names></name><etal></etal></person-group>
<article-title>Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET</article-title>. <source/>Nature (<year>1997</year>) <volume>385</volume>:<fpage>634</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/385634a0</pub-id><pub-id pub-id-type="pmid">9024661</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawaguchi</surname><given-names>T</given-names></name></person-group>. <article-title>The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task</article-title>. <source/>Neurosci Res (<year>2001</year>) <volume>41</volume>:<fpage>115</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1016/S0168-0102(01)00270-X</pub-id><pub-id pub-id-type="pmid">11591439</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>AG</given-names></name><name><surname>Ahn</surname><given-names>S</given-names></name><name><surname>Floresco</surname><given-names>SB</given-names></name></person-group>. <article-title>Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task</article-title>. <source/>J Neurosci (<year>2004</year>) <volume>24</volume>:<fpage>547</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1523/jneurosci.4653-03.2004</pub-id><pub-id pub-id-type="pmid">14724255</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aalto</surname><given-names>S</given-names></name><name><surname>Bruck</surname><given-names>A</given-names></name><name><surname>Laine</surname><given-names>M</given-names></name><name><surname>Nagren</surname><given-names>K</given-names></name><name><surname>Rinne</surname><given-names>JO</given-names></name></person-group>. <article-title>Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457</article-title>. <source/>J Neurosci (<year>2005</year>) <volume>25</volume>:<fpage>2471</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1523/jneurosci.2097-04.2005</pub-id><pub-id pub-id-type="pmid">15758155</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoof</surname><given-names>JC</given-names></name><name><surname>Kebabian</surname><given-names>JW</given-names></name></person-group>
<article-title>Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum</article-title>. <source/>Nature (<year>1981</year>) <volume>294</volume>:<fpage>366</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/294366a0</pub-id><pub-id pub-id-type="pmid">6273735</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoof</surname><given-names>JC</given-names></name><name><surname>Kebabian</surname><given-names>JW</given-names></name></person-group>. <article-title>Two dopamine receptors: biochemistry, physiology and pharmacology</article-title>. <source/>Life Sci (<year>1984</year>) <volume>35</volume>:<fpage>2281</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/0024-3205(84)90519-8</pub-id><pub-id pub-id-type="pmid">6390056</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>JZ</given-names></name><name><surname>Sek</surname><given-names>B</given-names></name><name><surname>Schorderet</surname><given-names>M</given-names></name></person-group>. <article-title>Bidirectional regulation of cAMP generating system by dopamine-D1 and D2-receptors in the rat retina</article-title>. <source/>J Neural Transm Gen Sect (<year>1990</year>) <volume>81</volume>:<fpage>235</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1007/BF01245045</pub-id><pub-id pub-id-type="pmid">1697754</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svenningsson</surname><given-names>P</given-names></name><name><surname>Lindskog</surname><given-names>M</given-names></name><name><surname>Ledent</surname><given-names>C</given-names></name><name><surname>Parmentier</surname><given-names>M</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Fredholm</surname><given-names>BB</given-names></name><etal></etal></person-group>
<article-title>Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2000</year>) <volume>97</volume>:<fpage>1856</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.97.4.1856</pub-id><pub-id pub-id-type="pmid">10677546</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lidow</surname><given-names>MS</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name><name><surname>Gallager</surname><given-names>DW</given-names></name><name><surname>Rakic</surname><given-names>P</given-names></name></person-group>. <article-title>Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390</article-title>. <source/>Neuroscience (<year>1991</year>) <volume>40</volume>:<fpage>657</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/0306-4522(91)90003-7</pub-id><pub-id pub-id-type="pmid">2062437</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name><name><surname>Cai</surname><given-names>JX</given-names></name><name><surname>Murphy</surname><given-names>BL</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys</article-title>. <source/>Psychopharmacology (Berl) (<year>1994</year>) <volume>116</volume>:<fpage>143</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1007/BF02245056</pub-id><pub-id pub-id-type="pmid">7862943</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism</article-title>. <source/>Arch Gen Psychiatry (<year>1998</year>) <volume>55</volume>:<fpage>362</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.55.4.362</pub-id><pub-id pub-id-type="pmid">9554432</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group>. <article-title>Implications of normal brain development for the pathogenesis of schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>1987</year>) <volume>44</volume>:<fpage>660</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.1987.01800190080012</pub-id><pub-id pub-id-type="pmid">3606332</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name><name><surname>Muly</surname><given-names>EC</given-names><suffix>III</suffix></name><name><surname>Williams</surname><given-names>GV</given-names></name></person-group>
<article-title>D(1) receptors in prefrontal cells and circuits</article-title>. <source/>Brain Res Brain Res Rev (<year>2000</year>) <volume>31</volume>:<fpage>295</fpage>–<lpage>301</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-0173(99)00045-4</pub-id><pub-id pub-id-type="pmid">10719156</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group>. <article-title>Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates</article-title>. <source/>Science (<year>1985</year>) <volume>230</volume>:<fpage>1273</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1126/science.2999977</pub-id><pub-id pub-id-type="pmid">2999977</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BM</given-names></name><name><surname>Mei</surname><given-names>ZT</given-names></name></person-group>. <article-title>Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys</article-title>. <source/>Behav Neural Biol (<year>1994</year>) <volume>62</volume>:<fpage>134</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S0163-1047(05)80034-2</pub-id><pub-id pub-id-type="pmid">7993303</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granon</surname><given-names>S</given-names></name><name><surname>Poucet</surname><given-names>B</given-names></name><name><surname>Thinus-Blanc</surname><given-names>C</given-names></name><name><surname>Changeux</surname><given-names>JP</given-names></name><name><surname>Vidal</surname><given-names>C</given-names></name></person-group>. <article-title>Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing</article-title>. <source/>Psychopharmacology (Berl) (<year>1995</year>) <volume>119</volume>:<fpage>139</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1007/BF02246154</pub-id><pub-id pub-id-type="pmid">7659760</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franowicz</surname><given-names>JS</given-names></name><name><surname>Arnsten</surname><given-names>AF</given-names></name></person-group>. <article-title>The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys</article-title>. <source/>Psychopharmacology (Berl) (<year>1998</year>) <volume>136</volume>:<fpage>8</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1007/s002130050533</pub-id><pub-id pub-id-type="pmid">9537677</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>ZM</given-names></name><name><surname>Arnsten</surname><given-names>AF</given-names></name><name><surname>Li</surname><given-names>BM</given-names></name></person-group>. <article-title>Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys</article-title>. <source/>Biol Psychiatry (<year>1999</year>) <volume>46</volume>:<fpage>1259</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-3223(99)00139-0</pub-id><pub-id pub-id-type="pmid">10560031</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anagnostaras</surname><given-names>SG</given-names></name><name><surname>Murphy</surname><given-names>GG</given-names></name><name><surname>Hamilton</surname><given-names>SE</given-names></name><name><surname>Mitchell</surname><given-names>SL</given-names></name><name><surname>Rahnama</surname><given-names>NP</given-names></name><name><surname>Nathanson</surname><given-names>NM</given-names></name><etal></etal></person-group>
<article-title>Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</article-title>. <source/>Nat Neurosci (<year>2003</year>) <volume>6</volume>:<fpage>51</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nn992</pub-id><pub-id pub-id-type="pmid">12483218</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>JM</given-names></name><name><surname>Collinsworth</surname><given-names>GP</given-names></name><name><surname>Gettys</surname><given-names>TW</given-names></name><name><surname>Raymond</surname><given-names>JR</given-names></name></person-group>. <article-title>Agonist-induced translocation of Gq/11alpha immunoreactivity directly from plasma membrane in MDCK cells</article-title>. <source/>Am J Physiol (<year>1999</year>) <volume>276</volume>:<fpage>F528</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">10198411</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lidow</surname><given-names>MS</given-names></name></person-group>. <article-title>Calcium signaling dysfunction in schizophrenia: a unifying approach</article-title>. <source/>Brain Res Brain Res Rev (<year>2003</year>) <volume>43</volume>:<fpage>70</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainresrev.2003.09.001</pub-id><pub-id pub-id-type="pmid">14499463</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirnics</surname><given-names>K</given-names></name><name><surname>Middleton</surname><given-names>FA</given-names></name><name><surname>Stanwood</surname><given-names>GD</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Levitt</surname><given-names>P</given-names></name></person-group>. <article-title>Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia</article-title>. <source/>Mol Psychiatry (<year>2001</year>) <volume>6</volume>:<fpage>293</fpage>–<lpage>301</lpage>.<pub-id pub-id-type="doi">10.1038/sj.mp.4000866</pub-id><pub-id pub-id-type="pmid">11326297</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peruzzi</surname><given-names>D</given-names></name><name><surname>Aluigi</surname><given-names>M</given-names></name><name><surname>Manzoli</surname><given-names>L</given-names></name><name><surname>Billi</surname><given-names>AM</given-names></name><name><surname>Di Giorgio</surname><given-names>FP</given-names></name><name><surname>Morleo</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Molecular characterization of the human PLC beta1 gene</article-title>. <source/>Biochim Biophys Acta (<year>2002</year>) <volume>1584</volume>:<fpage>46</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/S1388-1981(02)00269-X</pub-id><pub-id pub-id-type="pmid">12213492</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arinami</surname><given-names>T</given-names></name><name><surname>Ohtsuki</surname><given-names>T</given-names></name><name><surname>Ishiguro</surname><given-names>H</given-names></name><name><surname>Ujike</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Morita</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p</article-title>. <source/>Am J Hum Genet (<year>2005</year>) <volume>77</volume>:<fpage>937</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1086/498122</pub-id><pub-id pub-id-type="pmid">16380906</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>du Bois</surname><given-names>TM</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>XF</given-names></name></person-group>. <article-title>Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2005</year>) <volume>29</volume>:<fpage>878</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.pnpbp.2005.04.034</pub-id><pub-id pub-id-type="pmid">16005134</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Vasco</surname><given-names>VR</given-names></name><name><surname>Cardinale</surname><given-names>G</given-names></name><name><surname>Polonia</surname><given-names>P</given-names></name></person-group>. <article-title>Deletion of PLCB1 gene in schizophrenia-affected patients</article-title>. <source/>J Cell Mol Med (<year>2012</year>) <volume>16</volume>:<fpage>844</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01363.x</pub-id><pub-id pub-id-type="pmid">22507702</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didriksen</surname><given-names>M</given-names></name></person-group>. <article-title>Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm</article-title>. <source/>Eur J Pharmacol (<year>1995</year>) <volume>281</volume>:<fpage>241</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/0014-2999(95)00242-D</pub-id><pub-id pub-id-type="pmid">8521906</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aultman</surname><given-names>JM</given-names></name><name><surname>Moghaddam</surname><given-names>B</given-names></name></person-group>. <article-title>Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task</article-title>. <source/>Psychopharmacology (Berl) (<year>2001</year>) <volume>153</volume>:<fpage>353</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1007/s002130000590</pub-id><pub-id pub-id-type="pmid">11271408</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorelova</surname><given-names>NA</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name></person-group>. <article-title>Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro</article-title>. <source/>J Neurophysiol (<year>2000</year>) <volume>84</volume>:<fpage>75</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">10899185</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>FJ</given-names></name></person-group>. <article-title>Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons</article-title>. <source/>J Neurosci (<year>2003</year>) <volume>23</volume>:<fpage>2686</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">12684454</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlersberg</surname><given-names>M</given-names></name><name><surname>Hsiung</surname><given-names>SC</given-names></name><name><surname>Glickstein</surname><given-names>SB</given-names></name><name><surname>Liu</surname><given-names>KP</given-names></name><name><surname>Tamir</surname><given-names>H</given-names></name><name><surname>Schmauss</surname><given-names>C</given-names></name></person-group>. <article-title>Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin)</article-title>. <source/>J Neurochem (<year>2004</year>) <volume>90</volume>:<fpage>865</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02562.x</pub-id><pub-id pub-id-type="pmid">15287892</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlen</surname><given-names>M</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Lundberg</surname><given-names>E</given-names></name><name><surname>Jonasson</surname><given-names>K</given-names></name><name><surname>Forsberg</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Towards a knowledge-based Human Protein Atlas</article-title>. <source/>Nat Biotechnol (<year>2010</year>) <volume>28</volume>:<fpage>1248</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1038/nbt1210-1248</pub-id><pub-id pub-id-type="pmid">21139605</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlen</surname><given-names>M</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Hallstrom</surname><given-names>BM</given-names></name><name><surname>Lindskog</surname><given-names>C</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Mardinoglu</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Proteomics. Tissue-based map of the human proteome</article-title>. <source/>Science (<year>2015</year>) <volume>347</volume>:<fpage>1260419</fpage>.<pub-id pub-id-type="doi">10.1126/science.1260419</pub-id><pub-id pub-id-type="pmid">25613900</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>